Safety first: Tracking adverse events associated with new therapies for people with hemophilia

被引:1
|
作者
Recht, Michael [1 ,2 ]
机构
[1] Amer Thrombosis & Hemostasis Network, 67 Red Circle Rd, Rochester, NY 14626 USA
[2] Oregon Hlth & Sci Univ, Hemophilia Ctr, Portland, OR 97201 USA
关键词
clinical research; emicizumab; hemophilia; mortality; registry; EMICIZUMAB PROPHYLAXIS; FACTOR-VIII;
D O I
10.1111/jth.15188
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3 / 5
页数:3
相关论文
共 7 条
  • [1] New directions to develop therapies for people with hemophilia
    Gogia, Pooja
    Tarantino, Michael
    Schramm, Wolfgang
    Aledort, Louis
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (06) : 417 - 433
  • [2] Safety and Survival Associated with Biologic Therapies: First Report of the Biobadaguay on the Paraguayan-Uruguayan Registry of Adverse Events with Biologic Therapies
    de Abreu, Paloma
    Avila-Pedretti, Gabriela
    Morel, Zoilo
    Isabel Acosta, Maria
    Cabrera-Villalba, Sonia
    Melgarejo, Patricia
    Franco, Marco
    Delgadillo, Pedro
    Roman, Lourdes
    Gabriel Elizaur, Juan
    Paredes, Ernesto
    Octavio Cordovilla, Darwin
    Palleiro, Daniel
    Albanese, Miguel
    Mazzoleni, Julio
    REUMATOLOGIA CLINICA, 2020, 16 (05): : 396 - 404
  • [3] BIOBADADERM, the Spanish Registry of Adverse Events Associated With Biologic Drugs in Dermatology: First Report
    Rivera, R.
    Garcia-Doval, I.
    Carretero, G.
    Dauden, E.
    Sanchez-Carazo, J.
    Ferrandiz, C.
    Herrera, E.
    Alsina, M.
    Ferran, M.
    Lopez-Estebaranz, J. L.
    Gomez, F.
    Herranz, J. M.
    Carrascosa, J. M.
    Vanaclocha, F.
    ACTAS DERMO-SIFILIOGRAFICAS, 2011, 102 (02): : 132 - 141
  • [4] Hypoglycemia Associated With Hospitalization and Adverse Events in Older People Population-based cohort study
    Majumdar, Sumit R.
    Hemmelgarn, Brenda R.
    Lin, Meng
    McBrien, Kerry
    Manns, Braden J.
    Tonelli, Marcello
    DIABETES CARE, 2013, 36 (11) : 3585 - 3590
  • [5] Maintaining Physical Activity Is Associated with Reduced Major Adverse Cardiovascular Events in People Newly Diagnosed with Diabetes
    Kim, Duhoe
    Seo, Jaehun
    Ha, Kyoung Hwa
    Kim, Dae Jung
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2022, 31 (02) : 187 - 195
  • [6] Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus A propensity score-matched nationwide study
    Lee, Kuang-Tso
    Yeh, Yung-Hsin
    Chang, Shang-Hung
    See, Lai-Chu
    Lee, Cheng-Hung
    Wu, Lung-Sheng
    Liu, Jia-Rou
    Kuo, Chi-Tai
    Wen, Ming-Shien
    MEDICINE, 2017, 96 (28)
  • [7] New-Onset Atrial Fibrillation is Associated With Cardiovascular Events Leading to Death in a First Time Myocardial Infarction Population of 89 703 Patients With Long-Term Follow-Up: A Nationwide Study
    Bang, Casper N.
    Gislason, Gunnar H.
    Greve, Anders M.
    Bang, Christian A.
    Lilja, Alexander
    Torp-Pedersen, Christian
    Andersen, Per K.
    Kober, Lars
    Devereux, Richard B.
    Wachtell, Kristian
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (01): : e000382